Advancing sarcoma diagnostics with expanded DNA methylation-based classification

Expanded DNA methylation-based sarcoma classifier achieves 98% accuracy across 116 tumor sub-classes, significantly enhancing diagnostic precision for mesenchymal tumors.

• Why it matters: Accurate diagnosis of sarcomas is critical for effective clinical management, yet their diverse nature makes classification challenging, risking misdiagnosis and suboptimal treatment.
• What they did: Using a machine learning approach, researchers analyzed 4,377 methylation profiles from multiple institutions, validating the classifier across four independent cohorts and refining its ability to distinguish 62 sarcoma types.
• The result: The improved classifier provided definitive diagnoses or reclassifications in 6% of ambiguous cases and increased diagnostic confidence in 73% of validation cases, facilitating clinical adoption.